Other Headlines

Supplies and equipment were donated by Northern California hospitals.
HIMSS has released a new white paper -- Defining and Testing EMR Usability: Principles and Proposed Methods of EMR Usability Evaluation and Rating.
Toshiba America Medical Systems, Inc. has been named a winner in the fifth annual Progressive Manufacturing 100 Awards (PM100), sponsored by Managing Automation Media, a Thomas Publishing Company, LLC publication.
Letter to National HIT Coordinator points out problems in implementation for hospitals.
Survey shows 90 percent of companies surveyed have AdvaMed ethics policies in place.

Have News for Us?

Submit your news on the industry, people, or companies.

Forward to a Friend

More Industry Headlines

Healthcare Information Management Service (HIMSS) Releases New White Paper HIMSS has released a new white paper -- Defining and Testing EMR Usability: Principles and Proposed Methods of EMR Usability Evaluation and Rating.

AHA Proposes Changes to Draft Definition of "Meaningful Use" Letter to National HIT Coordinator points out problems in implementation for hospitals.

Independent Survey Indicates Med Tech Companies Have Broad Support for AdvaMed Code of Ethics Survey shows 90 percent of companies surveyed have AdvaMed ethics policies in place.

CareFusion Launches New Brand Cardinal health spinoff takes an important step toward going public later this summer.

ACR Talks to DOTmed About the Utilization Rate Controversy What the problems are, what possible solutions exist.

Medical Suppliers Go to "The Max" for Health Care Market Intelligence Vendors and distributors in the health care industry are increasingly turning to market intelligence tools to help them stay competitive in today's economy. Read DOTmed's profile of The Max, a leading medical market intelligence service.

VA Infections Spark Calls for More Oversight House committee calls for centralized control of the veterans' health system after a recent spate of infections that may be linked to faulty endoscope sterilization.

Health Reform Round-Up: House Committee Hearings Three days of recent testimony on the Hill focus on the draft proposal for health care reform. Read DOTmed's exclusive weekly update.

CMS Medicare Pay Plan Announced CMS proposes payment, policy changes for physician services to Medicare beneficiaries in 2010.

Chemical "Nose" Knows If We Have Cancer and Whether it's Metastatic Using nanoparticles and polymers, researchers at the University of Massachusetts Amherst have developed a fundamentally new way to differentiate healthy and cancerous cells.

Archives of Internal Medicine

Many Breast Cancers Appear to Resolve Without Treatment

by Barbara Kram, Editor
First, do no harm. Could that mean not treating breast cancer? It's hard to believe but a new study in the Archives of Internal Medicine (JAMA) showed that many invasive breast cancers in the group studied resolved on their own.

Per-Henrik Zahl, M.D., Ph.D., of the Norwegian Institute of Public Health, Oslo, and colleagues examined breast cancer rates among 119,472 women age 50 to 64 who were all invited to participate in three rounds of screening mammograms between 1996 and 2001 as part of the Norwegian Breast Cancer Screening Program. They compared these to rates among a control group of 109,784 women age 50 to 64 in 1992, who would have been invited for screening if the program had existed at that time. Cancers were tracked for six years using a national registry, and at the end of that time all participants were invited to undergo a one-time screening to assess breast cancer prevalence.

As anticipated, breast cancer rates were higher among screened women than among the control group before the final prevalence screening. "Even after prevalence screening in controls, however, the cumulative incidence of invasive breast cancer remained 22 percent higher in the screened group," the authors write. Of every 100,000 screened women, 1,909 had breast cancer during the six-year period, compared with 1,564 of every 100,000 in the control group. Screened women were more likely to have breast cancer at every age.

"Because the cumulative incidence among controls never reached that of the screened group, it appears that some breast cancers detected by repeated mammographic screening would not persist to be detectable by a single mammogram at the end of six years," the authors write. "This raises the possibility that the natural course of some screen-detected invasive breast cancers is to spontaneously regress."

"Although many clinicians may be skeptical of the idea, the excess incidence associated with repeated mammography demands that spontaneous regression be considered carefully," they continue. "Spontaneous regression of invasive breast cancer has been reported, with a recent literature review identifying 32 reported cases. This is a relatively small number given such a common disease. However, as some observers have pointed out, the fact that documented observations are rare does not mean that regression rarely occurs. It may instead reflect the fact that these cancers are rarely allowed to follow their natural course."

The findings do not answer the question of whether mammograms prevent deaths from breast cancer, the authors note. "Instead, our findings simply provide new insight on what is arguably the major harm associated with mammographic screening, namely, the detection and treatment of cancers that would otherwise regress," they conclude.


This finding could one day change protocols for screening. The risks of treatment, in cases where it is not called for, are significant such as radiation damage to the heart. The findings are controversial. The lead author had difficulty finding a journal to publish his statistical works.

"Uncertainty about the value of mammography continues," according to an editorial in the journal. "If the spontaneous remission hypothesis is credible, it should cause a major re-evaluation in the approach to breast cancer research and treatment. Certainly it is worthy of further evaluation."

Ultimately, suspicious lesions must be biopsied and, if cancerous, treated, most experts who commented on the study conclude, because it is not yet possible to know which cancers will progress and which will resolve.

Citation: The Natural History of Invasive Breast Cancers Detected by Screening Mammography, Archives of Internal Medicine 2008;168[21]:2311-2316.)

Read the abstract:
http://archinte.ama-assn.org/cgi/content/full/168/21/2311

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

Please Send us your Comments.

Printable Story
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2009 DOTmed.com, Inc.
ALL RIGHTS RESERVED